AsiaNet-Pakistan Premier Editorial Content and Press Release Distribution Service
Islamabad, Citi Pharma Ltd. (CPHL) announced moderate growth amidst market volatility at the Pakistan Stock Exchange (PSE). With a daily weighted average rate of Rs. 2,284.61, the pharmaceutical company continues to navigate through challenging market conditions. CPHL, listed since 2021, reported an EPS of Rs. 2.88 for the year 2022/2023, reflecting its steady performance in the sector. The company, with a paid-up capital of Rs. 27.26 million, did not declare any distributions for the year ending June. Despite market fluctuations, Citi Pharma remains resilient, with a book closure on October 20th and a market lot of 10 shares.
Check Also
Pakistan State Oil Reports Loss of Over 650 Shares
Karachi: Pakistan State Oil Company Limited (PSO) has reported the loss of share certificates totaling 657 shares, belonging to the deceased shareholder Mohammad Sharif Akhtar. This notification was made to the Pakistan Stock Exchange (PSX) as part of...
The post Pakistan State Oil Reports Loss of Over 650 Shares appeared first on .